Coronil has been awarded the CoPP licence as per WHO-GMP: Patanjali ANI | Updated: Feb 24, 2021 13:16 IST
New Delhi [India], February 24 (ANI): Coronil has been awarded the CoPP licence as per WHO-GMP. Dr Harsh Vardhan didn t endorse any ayurvedic medicine, neither, did he undermine the modern medicines, said Acharya Balkrishna, General Secretary, Patanjali Research Foundation Trust, Haridwar over IMA on Coronil.
A press release from Patanjali Research Foundation Trust read, Patanjali Research Foundation Trust, Haridwar is appalled by the press release issued by the officials of the Indian Medical Association, on CORONIL. It is disheartening to observe the lack of understanding of scientific research concepts by such well trained doctors.
Coronil An Evidence-Based Medicine With Scientifically Validated Research : Patanjali Counters IMA s Scathing Attack
swarajyamag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swarajyamag.com Daily Mail and Mail on Sunday newspapers.
IMA s remarks on Coronil uncalled for : Patanjali - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.
5644
1 The Indian Medical Association on Monday questioned Health Minister Harsh Vardhan about promoting Patanjaliâs âunscientificâ ayurvedic tablet Coronil as the first evidence-based medicine for Covid-19 and sought a public explanation from him.
New Delhi, February 22
The Indian Medical Association on Monday questioned Health Minister Harsh Vardhan about promoting Patanjali’s “unscientific” ayurvedic tablet Coronil as the first evidence-based medicine for Covid-19 and sought a public explanation from him.
“Being the Health Minister of the country and a modern medicine doctor, how ethical is it to promote an unscientific product before the country? How justified it is to release a false, fabricated and unscientific product? If Coronil is so effective, why spend Rs 35,000 crore on vaccinations?” IMA asked Vardhan in a letter.